Peripheral intravenous (PIV) catheters are the most commonly inserted invasive medical device in healthcare — with 330 million placed annually in the US. Despite their ubiquity, PIV complications (phlebitis, infiltration, occlusion, extravasation, and infection) affect 30–60% of placements, often requiring premature discontinuation and repeated insertion — a significant source of patient discomfort, hospital delay, and clinician workload. Evidence-based PIV insertion and maintenance practices significantly reduce these complication rates.
Optimal Site and Gauge Selection
Site selection hierarchy (preferred to avoided): forearm (preferred — most stable site, lowest phlebitis rate), dorsum of hand (acceptable), antecubital fossa (avoid — limits arm movement, increases occlusion, high phlebitis for long dwell), wrist (avoid — high phlebitis, painful), lower extremity (last resort — increased phlebitis and DVT risk). Catheter gauge and flow rate: 22G (0.9mL/s max), 20G (1.7mL/s), 18G (3.3mL/s), 16G (6.7mL/s). Gauge selection should match clinical need — routine medication administration (20–22G), blood transfusion (18–20G), rapid fluid resuscitation (16G or larger). Smaller gauge = less phlebitis (22G phlebitis rate 1.5× lower than 18G in meta-analyses). Valved catheters (Saf-T-Clik, SAF-T-Intima): reduce needlestick injury risk — OSHA recommendation for all PIV placements. Blood control features prevent blood exposure on catheter removal.
Dwell Time, Phlebitis Prevention, and Maintenance
Dwell time evidence: the 2019 RSVP trial (n=1,593): routine site change at 72–96 hours versus clinically indicated change — no significant difference in phlebitis rates. CDC 2011 guideline and Infusion Nursing Society 2021 guidelines now support clinically indicated replacement (remove when symptomatic or no longer needed) rather than routine 72-96-hour replacement — reducing unnecessary PIV replacements by 50%. Exceptions: catheters placed under suboptimal sterile conditions (emergency insertion) should be replaced within 24–48 hours. Phlebitis prevention: use of 0.9% NaCl flush (not heparin — CHAT trial showed no benefit of heparin over saline for PIV patency), volume-based flushing (10mL pre and post IV medication) versus standard 2–3mL, and limb elevation for early phlebitis. Chlorhexidine-impregnated dressings: significantly reduce PIV-related bloodstream infection risk versus standard polyurethane dressings (RR 0.51) — appropriate for immunocompromised patients and longer dwell catheters. Bundled prevention: PIV bundles including standardized insertion technique, documentation, daily assessment, and nurse-driven removal criteria reduce complication rates by 25–35% in quality improvement studies. Our IV vascular access catalog includes peripheral IV catheters, safety catheters, extension sets, flush syringes, and dressings — everything needed for evidence-based PIV insertion and maintenance programs. Our medical gloves section provides examination and sterile gloves for all procedural skill levels.
